FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Report a Drug Shortage | FAQ | Background Info | Get Email Alerts | Download Current Drug Shortages | Contact Us

Start Over | Back to Previous Screen

Sufentanil Citrate Injection
Status: Currently in Shortage
»Date first posted: 05/03/2022
»Therapeutic Categories: Analgesia/Addiction; Pediatric

Expand all

Hikma Pharmaceuticals USA, Inc. (Revised 05/17/2024)

Company Contact Information:
800-631-2174

Presentation	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per FDASIA)
Sufentanil Citrate Injection, USP, Injection, 50 mcg/1 mL (NDC 17478-050-01)	Unavailable	Not currently manufactured	Demand increase for the drug
Sufentanil Citrate Injection, USP, Injection, 50 mcg/1 mL (NDC 17478-050-02)	Unavailable	Not currently manufactured	Demand increase for the drug
Sufentanil Citrate Injection, USP, Injection, 50 mcg/1 mL (NDC 17478-050-05)	Unavailable	Not currently manufactured	Demand increase for the drug

Hospira, Inc., a Pfizer Company (Revised 05/15/2024)

Company Contact Information:
844-646-4398

Presentation	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per FDASIA)
Injection, 50 ug/1 mL (NDC 0409-3382-21)	Unavailable	Next Delivery: July 2024; Estimated Recovery: September 2024; Shortage per Manufacturer: Manufacturing Delay	Delay in shipping of the drug